Feminate

Treatment of iron deficiency anemia and folic acid deficiency.

Prophylactic: 1 unit od. Therapeutic: 1 unit bid.

Hypersensitivity to iron or to any of the component of Feminate. Hemosiderosis, hemochromatosis, hemolytic anemia. Folic acid is contraindicated in pernicious anemia and megaloblastic anemia caused by vitamin B12 deficiency.

Ferrous ascorbate was found to be effective, safe and well-tolerated in the treatment of iron deficiency anemia. Diarrhoea may occur in children which disappear within few days. Allergic sensitization may occur with folic acid. Other reported side effects with folic acid are anorexia, nausea, bitter/bad taste, irritability, confusion and altered sleep pattern.

Each tablet contains ferrous ascorbate equivalent to elemental iron 100 mg and folic acid 1.5 mg.

Feminate consists of ferrous ascorbate and folic acid. Ferrous ascorbate is a synthetic molecule of iron and ascorbic acid. Ferrous ascorbate is used as a source of iron deficiency anemia with molecular formula of C₁₂H₁₃FeO₂ and molecular weight of 406.1.

Folic acid, N-(p(((2-amino-4-hydroxy-6-pteridinyl)-methyl)amino)benzoyl) glutamic acid, is a complex organic compound present in liver, yeast and other substances, and which may be prepared synthetically with molecular formula of C₁₉H₁₉N₇O₆ and molecular weight of 441.4.